Biotechnology

Our biotechnology practice focuses on assisting research institutions, pharmaceutical companies, and biotechnology companies in formulating corporate policy on the development, acquisition, and exploitation of their biomedical assets, including patents.

We also negotiate and draft agreements for collaborative arrangements, including joint ventures and strategic alliances.

Select News & Events

• 2010 BIO International Convention Cocktail Reception
• After Ariad v. Lilly: Implications and Best Practices

Publications

• New Executive Order to Prompt Changes in Security Standards for Biolabs
  September 3, 2010
• Section 337 Update - April Activities Affecting the US International Trade Commission
  April 27, 2010
• The Curse Of The Traveling Shorts - Corporate Officer Narrowly Escapes Personal Liability, But An (Unnecessary?) Eight-Year Battle Lingers On
  February 12, 2010
• Court Voids US EPA Ban on Use of Third-Party Human Test Data
  Environmental & Chemical Regulatory Update
  June 2003

More Publications »